CyanVac, Immuno Technologies announce long-lasting Lyme vaccine results

CyanVac, Immuno Technologies announce long-lasting Lyme vaccine results

CyanVac LLC, a trailblazer in intranasal vaccine technology, in collaboration with Immuno Technologies, Inc., a leader in vaccines and diagnostics for Lyme disease, has unveiled promising preclinical data in NPJ Vaccines. The data reveal that mice inoculated with a Parainfluenza Virus 5 (PIV5)-based intranasal vaccine show long-lasting neutralizing antibody responses and extended protection of up […]

Pfizer to invest $95m in French specialty vaccine company Valneva

Pfizer to invest $95m in French specialty vaccine company Valneva

US pharma giant Pfizer said that it will invest $95 million in Valneva, a French specialty vaccine company, for an 8.1% stake. The two firms have signed an equity subscription agreement in this connection. Besides, they have amended the terms of their collaboration and license agreement for VLA15, a vaccine candidate for Lyme disease. Pfizer […]

Understanding Lyme Disease as the Great Imitator

Understanding Lyme Disease as the Great Imitator

For most adults and children, getting a tick bite is not a concerning experience. However, the increase in the number of cases of Lyme Disease throughout the world over the last several years has brought tick bites into the spotlight. In the UK, there are an estimated 1,000 cases of Lyme Disease diagnosed each year, […]